肺癌新輔助治療后的手術(shù)并發(fā)癥及術(shù)后生存率的研究.pdf

1、中國醫(yī)科大學(xué)碩士學(xué)位論文肺癌新輔助治療后的手術(shù)并發(fā)癥及術(shù)后生存率的研究姓名：劉思洋申請學(xué)位級別：碩士專業(yè)：胸外科指導(dǎo)教師：田大力20090401英文論著摘要operativecomplicationsandsurvivalrateafterinductiontherapyforlungcancerAimdiscussingtheperativecomplicationsandsurvivalrateafternewinductionth

2、erapyforlungcancerMethod10patients(8malesand2females)underwentnewinductionthempyandsurgeryforstageIIIAandBNSCLCThemeanagewas592yearsWeretrospectivelycollectedrelativedata，preoperativefunctionalparameters，typeofoperation，

3、staging，inductionregimen(chemotherapyaloneorassociated塒tIlradiotherapy)Result7patientsreceivedchemotherapy(mainlybasedoncisplatinandVP一16)and3receivedchemoradiotherapy(mediandose40Gy)Complicationsdevelopedin2pmiems(20％)1

4、patientspresentedpersistentairleakage(1O％)，1謝t11cerebralthrombosis(10％)ConclusionNewinductionther印yseemstobeassociated、析manincreasedincidenceofairleakage；theriskofothercomplicationsisacceptableNewinductiontherapyCanimpro